Breathe Well Live Well
|
Merck Announces Recipients of the 2011 "Will to Win"
CSRwire.com (press release) WHITE HOUSE STATION, NJ, Oct. 11 /CSRwire/ – Merck today announced the names of 10 outstanding high school seniors with asthma who have been selected as recipients of the 2011 Will to Win Scholarships. Each student has been awarded a $5000 scholarship … |
View full post on asthma – Google News
|
Merck partners with Habitat for Humanity in asthma awareness effort
Medical Marketing and Media Merck is launching Build Smart, Breathe Easier, an asthma awareness campaign starring celebrity carpenter Carter Oosterhouse, who will build four homes with asthma-healthy features. Oosterhouse, a fixture on HGTV, will build houses with low-income … |
View full post on asthma – Google News
 Daily Mail |
Astra, Merck asthma pills as good as inhaler: study
AsiaOne LONDON – Rarely prescribed asthma pills made by drugmakers such as AstraZeneca and Merck are easier to use and just as effective as conventional inhaler treatments, according to research by British scientists. In a study in the New England Journal of … Asthma Pills Work as Well as Inhaled Steroids: Study Pills better for treating asthma than inhalers Anti-Leukotrienes as Good as Standard Asthma Therapy |
View full post on asthma – Google News
 The Star-Ledger – NJ.com |
NJ's Merck forges partnership to develop new medicines for asthma and other …
The Star-Ledger – NJ.com Lycera is working on drug candidates that target two pathways, so called Th17 cells and RORyt, that play a critical role in immune-mediated diseases, including psoriasis, asthma and inflammatory bowel disease. Merck, which is based in Whitehouse … Merck and Lycera to Develop Oral Autoimmune Disease Drugs Targeting Th17 Cells |
View full post on asthma – Google News
|
Merck withdraws EMA filing for asthma combo Zenhale
Pharma Times Merck & Co has decided to pull a submission for its new asthma treatment Zenhale in Europe, after the regulator required more data. … |
View full post on asthma – Google News
|
Merck Withdraws Bid For EU Regulatory OK Of Asthma Medicine
Capital.gr (press release) (MRK) has withdrawn its application for European regulatory approval of an asthma treatment, citing outstanding questions by regulators. … |
View full post on asthma – Google News
|
Merck Withdraws Bid For EU Regulatory OK Of Asthma Medicine
Wall Street Journal (MRK) has withdrawn its application for European regulatory approval of an asthma treatment, citing outstanding questions by regulators. … |
View full post on asthma – Google News
|
Merck Withdraws Bid For EU Regulatory OK Of Asthma Medicine
NASDAQ (MRK) has withdrawn its application for European regulatory approval of an asthma treatment, citing outstanding questions by regulators. … |
View full post on asthma – Google News
|
Merck Announces Recipients of "Will to Win" Scholarship for Students With Asthma
CSRwire.com (press release) An independent panel of asthma experts from three national advocacy organizations evaluated many excellent applicant submissions and identified two … |
View full post on asthma – Google News
 Town Hall |
Merck to appeal $4.6M verdict in Mass. fraud case
The Associated Press Albuterol is a medicine that opens up airways for patients with asthma, bronchitis and chronic obstructive pulmonary disease. Usually, albuterol is supplied … Merck plans to appeal $4.6M Massachusetts judgment |
View full post on asthma – Google News